Categories Consumer

GM’s self-driving division secures $1.2-billion funding from investor group

The autonomous vehicle unit of General Motors (NYSE: GM ) received a big fillip this week after it secured a $1.15-billion funding from an investor group. After several rounds of funding – to the tune of $7.25 billion – GM Cruise is currently valued at $19 billion. The valuation represents nearly one-third of GM’s total market capitalization.

The latest investment was made by the parent company, Honda, SoftBank Vision Fund and a group of institutional investors. The funding that went into the development of the Cruise technology is expected to have well positioned the company to take on its rivals in the self-driving landscape.

Autonomous transport systems typically require heavy investment due to the challenges involved in perfecting the technology so as to meet the stringent regulatory norms. With competition growing in the segment, it is important for automakers to be ready with foolproof technology before they commence mass production.

The latest funding was raised from the parent company, Honda, SoftBank Vision Fund and institutional investors

According to the company, the latest funding gives it a “critical competitive advantage” by making a significant resource available. It is estimated that the lion’s share of the fund will be used for the previously announced expansion activities at the company’s Seattle facility, where it is planning to hire dozens of engineers by year-end.

Related: General Motors Q1 profit more than doubles

Earlier, Japan-based lender SoftBank had invested $2.25 billion in Cruise last year. A few months later, Cruise teamed up with Honda for designing the driver-less car, in a partnership that also included long-term investments of about $2 billion by the Japanese automaker.

GM shares gained more than 15% since the beginning of 2019, after hitting a low towards the end of last year. Having moved up around 5% over the past four quarters, the stock traded higher during Tuesday’s regular trading session.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top